Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ KAO Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA542085
Description
Peptide sequence: QFLHNNENIE NEDLVAWVTV GFLHIPHSED IPNTATPGNS VGFLLRPFNF Sequence homology: Cow: 86%; Dog: 93%; Guinea Pig: 93%; Horse: 100%; Human: 100%; Mouse: 92%; Pig: 100%; Rabbit: 93%; Rat: 100%; Zebrafish: 93%.
This gene encodes a metal-binding membrane glycoprotein that oxidatively deaminates putrescine, histamine, and related compounds. The encoded protein is inhibited by amiloride, a diuretic that acts by closing epithelial sodium ion channels. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Specifications
KAO | |
Polyclonal | |
Unconjugated | |
AOC1 | |
1600012D06Rik; Abp; abp1; amiloride binding protein 1 (amine oxidase (copper-containing)); amiloride binding protein 1 (amine oxidase, copper-containing); amiloride binding protein/diamine oxidase; amiloride-binding protein 1; amiloride-sensitive amine oxidase; amiloride-sensitive amine oxidase [copper-containing]; amine oxidase copper containing 1; Amine oxidase copper domain-containing protein 1; amine oxidase, copper containing 1; amine oxidase, copper-containing 1; aoc1; DAO; DAO1; Diamine oxidase; histaminase; KAO; kidney amine oxidase; si:ch211-286c5.2; zgc:154101 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
26 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
P19801 | |
AOC1 | |
Synthetic peptide directed towards the C-terminal of human ABP1 (aa 652-701). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction